King Pharmaceuticals Inc.

(NYSE:KG)

9.25

-0.38 (-3.95%)

Dec 04 - Close

Open
9.48
High
9.71
Low
9.02
Vol.
4.17M
Mkt Cap
2.37B
52Wk High
12.60
52Wk Low
6.98
Avg. Vol.
3.99M
P/E (Trailing)
8.72
Beta
0.65
Short %
3.60%
Div. Yield

After-Hours 9.24 -0.01 (-0.11%) Thu, 4 Dec 2008 7:40 PM

Company Profile

King Pharmaceuticals Inc.

501 Fifth Street

Bristol, TN 37620

United States - Map

Phone: (423) 989-8000

Fax: (423) 989-8711

Website: www.kingpharm.com

State of incorporation: Tennessee

CEO: Brian A. Markison

Employees: 2,050

Sector: Healthcare

Industry Group: Drugs

Industry: Drug Manufacturers - Other

A drug-maker.

A pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products.

Recent news for KG

Recent opinions on KG

No recent Opinions for KG

Top members owning KG

Members owning KG also own

XRAY (40.00%), ESGR (20.00%), VSNT (20.00%), KCI (20.00%), LO (20.00%)

Member sentiment: Neutral